annual SGA:
$7.25B-$49.79M(-0.68%)Summary
- As of today (May 29, 2025), TAK annual SGA is $7.25 billion, with the most recent change of -$49.79 million (-0.68%) on March 1, 2025.
- During the last 3 years, TAK annual SGA has fallen by -$642.32 million (-8.14%).
- TAK annual SGA is now -29.39% below its all-time high of $10.27 billion, reached on March 31, 2012.
Performance
TAK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$1.94B+$166.29M(+9.37%)Summary
- As of today (May 29, 2025), TAK quarterly SGA is $1.94 billion, with the most recent change of +$166.29 million (+9.37%) on March 1, 2025.
- Over the past year, TAK quarterly SGA has increased by +$18.45 million (+0.96%).
- TAK quarterly SGA is now -20.84% below its all-time high of $2.45 billion, reached on March 31, 2019.
Performance
TAK quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$34.50B-$1.26B(-3.51%)Summary
- As of today (May 29, 2025), TAK TTM SGA is $34.50 billion, with the most recent change of -$1.26 billion (-3.51%) on March 1, 2025.
- Over the past year, TAK TTM SGA has increased by +$27.20 billion (+373.02%).
- TAK TTM SGA is now -70.12% below its all-time high of $115.44 billion.
Performance
TAK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TAK Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.7% | +1.0% | +373.0% |
| 3 y3 years | -8.1% | +0.9% | +337.2% |
| 5 y5 years | -18.3% | -16.5% | +288.8% |
TAK Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | at low | at high | +12.0% | -34.1% | at low |
| 5 y | 5-year | -18.3% | at low | -16.5% | +12.0% | -36.0% | at low |
| alltime | all time | -29.4% | +151.9% | -20.8% | +56.2% | -70.1% | +51.3% |
TAK Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $7.25B(-0.7%) | $1.94B(+9.4%) | $7.25B(+0.3%) |
| Dec 2024 | - | $1.77B(-1.8%) | $7.23B(-0.5%) |
| Sep 2024 | - | $1.81B(+4.3%) | $7.27B(+0.8%) |
| Jun 2024 | - | $1.73B(-9.9%) | $7.22B(-1.0%) |
| Mar 2024 | $7.30B(-1.1%) | $1.92B(+6.1%) | $7.29B(-0.1%) |
| Dec 2023 | - | $1.81B(+3.5%) | $7.30B(-0.7%) |
| Sep 2023 | - | $1.75B(-3.2%) | $7.35B(-0.7%) |
| Jun 2023 | - | $1.81B(-6.3%) | $7.40B(+0.3%) |
| Mar 2023 | $7.39B(-6.5%) | $1.93B(+3.7%) | $7.38B(+0.1%) |
| Dec 2022 | - | $1.86B(+3.3%) | $7.37B(-2.3%) |
| Sep 2022 | - | $1.80B(+0.8%) | $7.54B(-1.6%) |
| Jun 2022 | - | $1.79B(-7.1%) | $7.67B(-2.8%) |
| Mar 2022 | $7.90B(-4.4%) | $1.92B(-5.4%) | $7.89B(-3.5%) |
| Dec 2021 | - | $2.03B(+5.5%) | $8.18B(-1.2%) |
| Sep 2021 | - | $1.93B(-4.1%) | $8.28B(-1.3%) |
| Jun 2021 | - | $2.01B(-9.2%) | $8.39B(+1.5%) |
| Mar 2021 | $8.26B(-6.9%) | $2.21B(+3.8%) | $8.26B(-1.3%) |
| Dec 2020 | - | $2.13B(+4.6%) | $8.37B(-1.9%) |
| Sep 2020 | - | $2.04B(+8.4%) | $8.53B(-0.5%) |
| Jun 2020 | - | $1.88B(-19.1%) | $8.58B(-3.3%) |
| Mar 2020 | $8.88B(+37.1%) | $2.32B(+1.4%) | $8.87B(-1.4%) |
| Dec 2019 | - | $2.29B(+10.1%) | $9.00B(+11.5%) |
| Sep 2019 | - | $2.08B(-4.4%) | $8.07B(+10.2%) |
| Jun 2019 | - | $2.18B(-11.2%) | $7.33B(+13.1%) |
| Mar 2019 | $6.47B | $2.45B(+79.6%) | $6.48B(+15.4%) |
| Dec 2018 | - | $1.37B(+2.3%) | $5.61B(-0.8%) |
| Sep 2018 | - | $1.33B(+0.4%) | $5.66B(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $1.33B(-16.1%) | $5.69B(+0.3%) |
| Mar 2018 | $5.67B(-1.0%) | $1.58B(+12.5%) | $5.67B(+0.1%) |
| Dec 2017 | - | $1.41B(+3.2%) | $5.67B(+0.9%) |
| Sep 2017 | - | $1.36B(+4.0%) | $5.62B(-1.1%) |
| Jun 2017 | - | $1.31B(-16.9%) | $5.68B(-0.5%) |
| Mar 2017 | $5.72B(+5.6%) | $1.58B(+16.2%) | $5.71B(+1.0%) |
| Dec 2016 | - | $1.36B(-4.6%) | $5.65B(+0.5%) |
| Sep 2016 | - | $1.43B(+6.3%) | $5.62B(+3.4%) |
| Jun 2016 | - | $1.34B(-11.8%) | $5.44B(+0.2%) |
| Mar 2016 | $5.42B(-3.2%) | $1.52B(+14.0%) | $5.43B(+1.0%) |
| Dec 2015 | - | $1.33B(+7.4%) | $5.37B(-0.4%) |
| Sep 2015 | - | $1.24B(-6.8%) | $5.39B(-3.0%) |
| Jun 2015 | - | $1.33B(-9.0%) | $5.56B(-0.1%) |
| Mar 2015 | $5.60B(+0.9%) | $1.47B(+8.2%) | $5.57B(-1.1%) |
| Dec 2014 | - | $1.35B(-4.0%) | $5.63B(-0.4%) |
| Sep 2014 | - | $1.41B(+5.5%) | $5.65B(+1.5%) |
| Jun 2014 | - | $1.34B(-12.6%) | $5.57B(+0.4%) |
| Mar 2014 | $5.55B(-10.5%) | $1.53B(+11.1%) | $5.54B(+38.1%) |
| Dec 2013 | - | $1.38B(+4.0%) | $4.01B(+52.2%) |
| Sep 2013 | - | $1.32B(+0.9%) | $2.64B(+100.9%) |
| Jun 2013 | - | $1.31B | $1.31B |
| Mar 2013 | $6.21B(-39.6%) | - | - |
| Mar 2012 | $10.27B(+20.4%) | - | - |
| Mar 2011 | $8.53B(+4.1%) | - | - |
| Mar 2010 | $8.20B(-13.5%) | - | - |
| Mar 2009 | $9.48B(+60.5%) | - | - |
| Mar 2008 | $5.91B(+105.1%) | - | - |
| Mar 2000 | $2.88B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual SGA?
- What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly SGA?
- What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM SGA?
- What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?
What is Takeda Pharmaceutical Company Limited annual SGA?
The current annual SGA of TAK is $7.25B
What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual SGA is $10.27B
What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?
Over the past year, TAK annual SGA has changed by -$49.79M (-0.68%)
What is Takeda Pharmaceutical Company Limited quarterly SGA?
The current quarterly SGA of TAK is $1.94B
What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly SGA is $2.45B
What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?
Over the past year, TAK quarterly SGA has changed by +$18.45M (+0.96%)
What is Takeda Pharmaceutical Company Limited TTM SGA?
The current TTM SGA of TAK is $34.50B
What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM SGA is $115.44B
What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?
Over the past year, TAK TTM SGA has changed by +$27.20B (+373.02%)